We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.

Tuberous sclerosis complex (TSC) is a genetic disorder caused by mutations in either of the two tumor suppressor genes TSC1 or TSC2, which encode hamartin and tuberin, respectively. Tuberin and hamartin form a complex that inhibits signaling by the mammalian target of rapamycin (mTOR), a critical nutrient sensor and regulator of cell growth and proliferation. Phosphatidylinositol 3-kinase (PI3K) inactivates the tumor suppressor complex and enhances mTOR signaling by means of phosphorylation of tuberin by Akt. Importantly, cellular transformation mediated by phorbol esters and Ras isoforms that poorly activate PI3K promote tumorigenesis in the absence of Akt activation. In this study, we show that phorbol esters and activated Ras also induce the phosphorylation of tuberin and collaborates with the nutrient-sensing pathway to regulate mTOR effectors, such as p70 ribosomal S6 kinase 1 (S6K1). The mitogen-activated protein kinase (MAPK)-activated kinase, p90 ribosomal S6 kinase (RSK) 1, was found to interact with and phosphorylate tuberin at a regulatory site, Ser-1798, located at the evolutionarily conserved C terminus of tuberin. RSK1 phosphorylation of Ser-1798 inhibits the tumor suppressor function of the tuberin/hamartin complex, resulting in increased mTOR signaling to S6K1. Together, our data unveil a regulatory mechanism by which the Ras/MAPK and PI3K pathways converge on the tumor suppressor tuberin to inhibit its function.

Pubmed ID: 15342917 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Cell Line | Enzyme Activation | Humans | MAP Kinase Signaling System | Models, Biological | Molecular Sequence Data | Mutation | Oncogene Protein p21(ras) | Phosphatidylinositol 3-Kinases | Phosphorylation | Phosphoserine | Protein Binding | Protein Kinases | Protein-Serine-Threonine Kinases | Proteins | Proto-Oncogene Proteins | Proto-Oncogene Proteins c-akt | Repressor Proteins | Ribosomal Protein S6 Kinases, 90-kDa | Serine | TOR Serine-Threonine Kinases | Tetradecanoylphorbol Acetate | Tuberous Sclerosis | Tumor Suppressor Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: R01 CA046595
  • Agency: NCI NIH HHS, Id: R37 CA046595
  • Agency: NIGMS NIH HHS, Id: GM 51405
  • Agency: NIGMS NIH HHS, Id: R01 GM051405
  • Agency: NHGRI NIH HHS, Id: T32 HG000041
  • Agency: NHGRI NIH HHS, Id: K22 HG000041
  • Agency: NHGRI NIH HHS, Id: HG 00041
  • Agency: NCI NIH HHS, Id: CA 46595

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.